Suchergebnisse - "Kow, Chia Siang"

PubPharm (73)

1

Optimal time for the resumption of biologics after COVID-19

enthalten in: JAAD international | 2020

von Kow, C. | Hasan, S.

2

Prevalence of Frailty in Patients with COVID-19: A Meta-Analysis

enthalten in: The journal of Frailty & Aging | 2020

von Kow, C. | Hasan, S.

3

Prevalence of Frailty in Patients with COVID-19: A Meta-Analysis

enthalten in: The journal of Frailty & Aging | 2020

von Kow, C. | Hasan, S.

4

Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease

enthalten in: Rheumatology international | 2020

von Kow, C. | Hasan, S.

CommentOn: Rheumatol Int. 2020 Dec;40(12):2015-2021. - PMID 32945944

5

Mortality and Disease Severity Among COVID-19 Patients Receiving Renin-Angiotensin System Inhibitors : A Systematic Review and Meta-analysis

enthalten in: American journal of cardiovascular drugs : drugs, devices, and other interventions | 2020

von Hasan, S. | Kow, C. | Hadi, M. | +2

6

Anticoagulant approach in COVID-19 patients with cerebral venous thrombosis

enthalten in: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association | 2020

von Kow, C. | Zaihan, A. | Hasan, S.

CommentOn: J Stroke Cerebrovasc Dis. 2020 Aug;29(8):104989. - PMID 32689590

7

Use of hydroxychloroquine and chloroquine in COVID-19 : How good is the quality of randomized controlled trials?

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2020

von Mazhar, F. | Hadi, M. | Kow, C. | +3

8

The Potential Benefit of Telmisartan to Protect Overweight Patients with COPD from the Acquisition of COVID-19

enthalten in: Obesity (Silver Spring, Md.) | 2020

von Kow, C. | Hasan, S.

9

Use of Pharmacologic Agents With Weight Gain Potential for Panic Disorder Amid the COVID-19 Pandemic

enthalten in: The primary care companion for CNS disorders | 2020

von Kow, C. | Hasan, S.

CommentOn: Prim Care Companion CNS Disord. 2020 Apr 30;22(3):. - PMID 32369687

10

CYP2C19 Genotype-Guided Antiplatelet Therapy Among Asian Patients with Ischaemic Stroke

enthalten in: Clinical drug investigation | 2020

von Kow, C. | Zaihan, A. | Hasan, S.

1
2
3
4
5
6
7
8
Nächster »
[8]